Cancer BiologybioRxiv
Targeting RET Kinase in Neuroendocrine Prostate Cancer
H. VanDeusen, J. R. Ramroop, K. L. Morel…·J. M. Drake
The paper identifies RET kinase as a targetable driver in neuroendocrine prostate cancer (NEPC) through phosphoproteomics and pharmacological inhibition studies, showing reduced tumor growth in models.
DOI 10.1158/1541-7786.mcr-19-1245